Dr Kelly Waldeck
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
20 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Carbonic Anhydrase-IX Is a Specific and Sensitive Theragnostic Target for Imaging and Radioimmunotherapy in Metastatic Colorectal Cancer
DOI: 10.1016/j.gastha.2025.1008712023
Journal article
A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177Lutetium-DOTA-octreotate radionuclide therapy
DOI: 10.7150/thno.846282022
Conference Proceedings
A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMOURS AND ATYPICAL TERATOID RHABDOID TUMOURS
DOI: 10.1093/neuonc/noac079.0162021
Journal article
gd T cells in merkel cell carcinomas have a proinflammatory profile prognostic of patient survival
DOI: 10.1158/2326-6066.CIR-20-08172020
Journal article
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer
DOI: 10.1021/acs.jmedchem.0c002912020
Journal article
Enhancing the anti-tumour activity of 177Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP
DOI: 10.1038/s41598-020-67199-92019
Journal article
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention
DOI: 10.1002/anie.201908964
RECENT SCHOLARLY WORKS
2018
Journal article
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance
DOI: 10.1002/ijc.312202016
Journal article
Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model
DOI: 10.1002/ijc.300562015
Journal article
UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas
DOI: 10.1158/0008-5472.CAN-15-1877